Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for ADHD in kids and individuals. In Canada, its distribution is overseen by Health Canada. This overview seeks to present understandable information on its indications, possible risks, appropriate administration, and cruci… Read More